# To Evaluate the Response to Glucagon During Hypoglycemia

> **NCT00817271** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 8 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** AZD1656
- **DRUG:** Glucagon

## Key facts

- **NCT ID:** NCT00817271
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2009-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00817271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00817271, "To Evaluate the Response to Glucagon During Hypoglycemia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00817271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*